ARCHIVES

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

Rall, FDA Chief On AACR Panel

April 27, 1979

DeVita Alert Advises That Negative Node Breast Cancer Patients Do Better With Adjuvant Therapy

May 27, 1988

HHS Carcinogen Guidelines Draft

June 6, 1980

OPR Reinstates Duke Medical Center’s License To Conduct Human Studies

May 28, 1999

Patients Who Smoke In Treatment Do Worse Than Those Who Quit

March 25, 2011

In Brief: George Vande Woude To Wistar institute Board; Donald Pinkel To Head Pediatric Leukemia Program

October 18, 1985